Yutaka Sugiyama
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: August 08, 2023
Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma.
Journal: IJU case reports
Published: July 06, 2022
Efficacy of Androgen Receptor-targeted Drugs After Prostate Cancer Recurrence With Bone Metastases: PROSTAT-BSI Sub-analysis.
Journal: Anticancer research
Published: April 18, 2022
Clear cell carcinoma of the seminal vesicle in a young adult.
Journal: IJU case reports
Published: March 20, 2022
Summary of the Clinical Practice Guidelines for Penile Cancer 2021 by the Japanese Urological Association.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: February 03, 2022
Subcapsular renal hematoma after ureterorenoscopy.
Journal: IJU case reports
Published: January 28, 2022
Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: January 25, 2022
Efficacy of New Therapies for Relapse After Docetaxel Treatment of Bone Metastatic Castration-resistant Prostate Cancer in Clinical Practice.
Journal: Anticancer research
Published: December 23, 2021
Successful Management for Refractory Non-Seminomatous Testicular Cancer with Retroperitoneal Lymph Node, Liver, Lung and Brain Metastases : A Case Report
Journal: Hinyokika kiyo. Acta urologica Japonica
Published: October 06, 2021
Erratum to: Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma.
Journal: Japanese journal of clinical oncology
Published: May 24, 2021
Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma.
Journal: Japanese journal of clinical oncology
Published: May 24, 2021
High T-cell infiltration in tumor tissue and younger age predict the response to pembrolizumab in recurrent urothelial cancer.
Journal: Medical molecular morphology
Published: March 28, 2021
Last Updated: 09/26/2026